Teva Pharmaceuticals Srl × Antineoplazice (Rev.2)
All direct purchases by the company to public hospitals in category „Antineoplazice (Rev.2)", most recent first.
4purchases · 2019-12-10 – 2019-12-17
21 k leitotal value
1hospitals
| Date | What | Estimated | Value | Quantity | Hospital | No. | Category | CPV code |
|---|---|---|---|---|---|---|---|---|
| 2019-12-17 | EPISINDAN 10 mg ( EPIRUBICINUM 10 mg ) | — | 2,335 lei | — | Spitalul Municipal Caracal | DA24750581 | Antineoplazice (Rev.2) | 33652100-6 |
| 2019-12-17 | EPIRUBICINA TEVA 50mg ( EPIRUBICINUM 2mg/25ml) | — | 9,257 lei | — | Spitalul Municipal Caracal | DA24749589 | Antineoplazice (Rev.2) | 33652100-6 |
| 2019-12-10 | EPIRUBICINA TEVA 50mg ( EPIRUBICINUM 2mg/25ml) | — | 4,629 lei | — | Spitalul Municipal Caracal | DA24659070 | Antineoplazice (Rev.2) | 33652100-6 |
| 2019-12-10 | EPISINDAN 10 mg ( EPIRUBICINUM 10 mg ) | — | 4,670 lei | — | Spitalul Municipal Caracal | DA24658088 | Antineoplazice (Rev.2) | 33652100-6 |
Filters on every column: plain text, a|b (any), !x (without), >1000, 10-50, >2 mil. Click a header to sort; "Columns" hides/shows; export takes only what is filtered. The column filters and sorting work on the open page; the search above and the links (hospital, supplier, category) narrow the whole list.